Carlos Manrique, MD
See Publications

Texas Heart Institute Positions

  • Fellow , Cardiovascular Disease Fellowship
  • Fellow, Advanced Heart Failure Fellowship

Education

  • Medical School:

    Pontifica Universidad Javeriana

  • Residency:

    Jacobi Medical Center, Albert Einstein College of Medicine

Publications

Manrique, C. R., Tiwari, N. and Plana, J. C. (2017). Cardiac Rhythm Disturbances. In Anti-Cancer Treatments and Cardiotoxicity (95–103). Elsevier. https://doi.org/10.1016/B978-0-12-802509-3.00013-3.
Manrique, C. R. and Plana, J. C. (2017). Atrial Fibrillation and Stroke in Cancer Patients. In Anti-Cancer Treatments and Cardiotoxicity (131–138). Elsevier. https://doi.org/10.1016/B978-0-12-802509-3.00019-4.
Manrique, C. R., Park, M., Tiwari, N. et al. (2017). Diagnostic strategies for early recognition of cancer therapeutics-related cardiac dysfunction. Clin Med Insights Cardiol 11, 1179546817697983. https://doi.org/10.1177/1179546817697983.
Yu, A. F., Manrique, C., Pun, S. et al. (2016). Cardiac safety of paclitaxel plus trastuzumab and pertuzumab in patients with HER2-positive metastatic breast cancer. Oncologist 21, 418–424. https://doi.org/10.1634/theoncologist.2015-0321.
Wever-Pinzon, O., Romero, J., Kelesidis, I. et al. (2014). Coronary computed tomography angiography for the detection of cardiac allograft vasculopathy: a meta-analysis of prospective trials. J Am Coll Cardiol 63, 1992–2004. https://doi.org/10.1016/j.jacc.2014.01.071.
Steingart, R. M., Yadav, N., Manrique, C. et al. (2013). Cancer survivorship: cardiotoxic therapy in the adult cancer patient; cardiac outcomes with recommendations for patient management. Semin Oncol 40, 690–708. https://doi.org/10.1053/j.seminoncol.2013.09.010.
Romero, J., Mejia-Lopez, E., Manrique, C. et al. (2013). Arrhythmogenic right ventricular cardiomyopathy (ARVC/D): a systematic literature review. Clin Med Insights Cardiol 7, 97–114. https://doi.org/10.4137/CMC.S10940.